Cargando…
Approved Beta Interferons in Relapsing-Remitting Multiple Sclerosis: Is There an Odd One Out?
Three interferons are marketed for the treatment of relapsing-remitting multiple sclerosis. In its pivotal trial, one of them demonstrated impressive efficacy as a once-weekly regimen, but later head-to-head studies and reviews questioned its superiority. Analysis of this pivotal trial in publicatio...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Libertas Academica
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3619495/ https://www.ncbi.nlm.nih.gov/pubmed/23662092 http://dx.doi.org/10.4137/JCNSD.S10150 |